Literature DB >> 27171521

Unilateral Conjunctival in situ Squamous Carcinoma with Bilateral Conjunctival Chlorpromazine-Induced Secondary Melanosis Masquerading as in situ and Invasive Melanoma.

Katharine S Sears1, Ian G Rennie2, Hardeep Singh Mudhar3.   

Abstract

PURPOSE: To describe the clinical and histopathological features of a 61-year-old male with a history of eczema, asthma and schizophrenia on long-term chlorpromazine medication, who developed a unilateral limbal tumour in association with bilateral melanosis. PROCEDURES: The patient was referred for a routine cataract assessment, and an incidental pink gelatinous limbal lesion was detected on the left side, associated with bilateral speckled brown conjunctival pigmentation. The limbal lesion and brown pigmentation were biopsied. The tissue was fixed in standard buffered formalin and processed to paraffin wax, and sections were stained with haematoxylin and eosin. Tissue from the pigmented area was also processed for transmission electron microscopy.
RESULTS: The biopsy from the limbal lesion showed an in situ squamous carcinoma associated with prominent numbers of intra-epithelial eosinophils. The biopsy of the pigmented area showed bilateral melanosis without atypia. The latter was attributable to an increase in melanin production rather than to melanocyte hyperplasia. Melanophages were also present in the adjacent substantia propria. These pigment changes were entirely compatible with chlorpromazine-induced secondary melanosis.
CONCLUSIONS: This paper highlights the first documented occurrence of in situ squamous carcinoma with bilateral chlorpromazine-induced conjunctival secondary melanosis. This clinically masqueraded as in situ melanoma/primary acquired melanosis and invasive melanoma. Bilateral melanosis is rare, has many causes and, in this case, was drug induced. This highlights the importance of thorough history taking and illustrates that not all pigmented and amelanotic lesions are in situ melanomas, primary acquired melanosis or invasive melanomas. Lastly, atopy was a risk factor for the development of this in situ squamous carcinoma.

Entities:  

Keywords:  Bilateral melanosis; Chlorpromazine; Conjunctival in situ squamous carcinoma; Masquerade

Year:  2015        PMID: 27171521      PMCID: PMC4847197          DOI: 10.1159/000375343

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  18 in total

1.  Perilimbal conjunctival pigmentation in vernal keratoconjunctivitis: a new sign.

Authors:  Srinivas K Rao; Prema Padmanabhan
Journal:  Cornea       Date:  2002-05       Impact factor: 2.651

2.  The Carney complex with ocular signs suggestive of cardiac myxoma.

Authors:  R H Kennedy; J C Flanagan; R C Eagle; J A Carney
Journal:  Am J Ophthalmol       Date:  1991-06-15       Impact factor: 5.258

3.  Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Authors:  Jerry A Shields; Carol L Shields; Arman Mashayekhi; Brian P Marr; Raquel Benavides; Archana Thangappan; Laura Phan; Ralph C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  2007

4.  Periocular pigmentation in the Peutz-Jeghers syndrome.

Authors:  E I Traboulsi; I H Maumenee
Journal:  Am J Ophthalmol       Date:  1986-07-15       Impact factor: 5.258

5.  Ocular changes in benign Acanthosis nigricans.

Authors:  P A Lamba; S Lal
Journal:  Dermatologica       Date:  1970

6.  Conjunctival intra-epithelial neoplasia occurring in young patients with asthma.

Authors:  P Rundle; H S Mudhar; I Rennie
Journal:  Eye (Lond)       Date:  2009-12-04       Impact factor: 3.775

7.  Ocular pigmented spots and eyelid myxomas.

Authors:  R H Kennedy; R R Waller; J A Carney
Journal:  Am J Ophthalmol       Date:  1987-11-15       Impact factor: 5.258

8.  Premalignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum.

Authors:  A D Paridaens; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

9.  Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation.

Authors:  J S Pulido; T J Flotte; H Raja; S Miles; J L Winters; R Niles; E A Jaben; S N Markovic; J Davies; K R Kalli; R G Vile; J J Garcia; D R Salomao
Journal:  Eye (Lond)       Date:  2013-06-21       Impact factor: 3.775

Review 10.  Benign conjunctival melanocytic lesions. Clinicopathologic features.

Authors:  R Folberg; F A Jakobiec; V B Bernardino; T Iwamoto
Journal:  Ophthalmology       Date:  1989-04       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.